Adverse events (AEs) with maintenance olaparib in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): Phase III SOLO1 trial Meeting Abstract
| Authors: | Colombo, N.; Moore, K. N.; Scambia, G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A. S.; Floquet, A.; Leary, A.; Sonke, G. S.; Gourley, C.; Banerjee, S. N.; Oza, A. M.; González-Martín, A.; Aghajanian, C.; Bradley, W. H.; Kim, J. W.; Lowe, E. S.; Bloomfield, R.; Disilvestro, P. |
| Abstract Title: | Adverse events (AEs) with maintenance olaparib in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): Phase III SOLO1 trial |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 323s |
| Language: | English |
| ACCESSION: | WOS:000487345805532 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.5539 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5539 -- Source: Wos |
